Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus

Hepatology. 2014 May;59(5):1688-91. doi: 10.1002/hep.26903. Epub 2014 Mar 1.

Authors

Andrew Aronsohn¹, Nancy Reau, Donald Jensen

Affiliation

¹ Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medical Center, Chicago, IL; MacLean Center for Clinical Medical Ethics, University of Chicago Medical Center, Chicago, IL.

PMID: 24806752
DOI: 10.1002/hep.26903

No abstract available

MeSH terms

Acquired Immunodeficiency Syndrome / drug therapy
Antiviral Agents / therapeutic use*
Drug Industry
Drug and Narcotic Control
Hepatitis B / drug therapy
Hepatitis C / drug therapy*
Humans
Off-Label Use*
United States
United States Food and Drug Administration

Substances

Antiviral Agents